Azevan Pharmaceuticals is a company specializing in therapeutics for stress-related CNS disorders and neurodegenerative conditions. It develops drugs that block the effects of arginine vasopressin (AVP). The company offers SRX246 and SRX251 clinical candidates aimed to reduce measures of stress, fear, aggression, depression, and anxiety in preclinical models.